(Q37953332)

25 August 2017

title

Multiple sclerosis and depression. (English)

1 reference

25 August 2017

0 references

Anthony Feinstein

1

1 reference

25 August 2017

language of work or name

1 reference

1 November 2011

1 reference

Multiple Sclerosis Journal

25 August 2017

published in

1 reference

25 August 2017

volume

17

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1276-1281

1 reference

Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Multiple sclerosis, depression, and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Social relationships, knowledge and adjustment to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Treatment of depression for patients with multiple sclerosis in neurology clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Affective disorders in multiple sclerosis. Review and recommendations for clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Major depression in multiple sclerosis: a population-based perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Suicide and multiple sclerosis: an epidemiological investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Clinical correlates of CES-D depressive symptom ratings in an MS population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

The association of depression with disease course in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Structural brain abnormalities in multiple sclerosis patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Involvement of the limbic system in multiple sclerosis patients with depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Relationship between coping, cognitive dysfunction and depression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Antidepressant pharmacotherapy of depression associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Telephone-administered psychotherapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Electroconvulsive therapy in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

The Goldman Consensus statement on depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511417835

21 January 2018

Identifiers

DOI

10.1177/1352458511417835

1 reference

25 August 2017

1 reference